Diagnosis of PML-associated visual impairment is a dubious disease in the field of the nervous system, with clinical performance being complex and often involving multi-system congestion. Early identification and standardized clinical care are essential for improving prognosis. Diagnosis of PML-associated visual impairment requires a combination of clinical performance, imaging inspection, laboratory testing and pathological activation.
The platform can assist in matching the needs of a team of nationally and internationally authoritative experts to provide accurate diagnosis and treatment programs. Individualised development of treatment programs for the treatment and management of PML-associated visual impairment, typically including drug therapy, rehabilitation interventions, and regular follow-up to multidimensional management. In recent years, with the development of treatment-oriented, immune-regulatory therapy and precision medicine, many of the neural system disorders that have been difficult to treat have been significantly improved.
Treatment needs to be closely monitored for efficacy and adverse reactions, adjusted in a timely manner according to changes in the condition. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of PML-associated vision disorders. 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.